V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20160601 | 20061929 | 1.74 | 66 | Neo-adjuvant (N) | 2019-01-05 | 2019-01-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101042172 |
| 20160602 | 20061930 | 1.67 | 60 | Adjuvant (A) | 2018-10-22 | 2018-11-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100157384 |
| 20160605 | 20061931 | 1.65 | 92 | Palliative (P) | 2019-08-21 | 2019-08-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101563367 |
| 20160606 | 20061932 | 1.78 | 92.6 | Adjuvant (A) | 2019-11-13 | 2019-11-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101507233 |
| 20160611 | 20061933 | 1.8 | 78.3 | Curative (C) | 2018-06-24 | 2018-07-12 | ECX | N | N | ECX | 101854589 |
| 20160614 | 20061934 | 1.64 | 102 | Palliative (P) | 2018-11-11 | 2018-11-14 | ECX | N | N | ECX | 101135418 |
| 20160615 | 20061935 | 1.6 | 86.6 | Palliative (P) | 2018-05-16 | 2018-05-19 | ECX | 02 | N | ECX | 101400728 |
| 20160616 | 20061936 | 1.5 | 63.4 | Adjuvant (A) | 2019-07-30 | 2019-08-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101137282 |
| 20160618 | 20061937 | 1.87 | 61.2 | Neo-adjuvant (N) | 2016-10-05 | 2016-10-15 | ECX | 02 | N | ECX | 101614426 |
| 20160619 | 20061938 | 1.73 | 72 | Neo-adjuvant (N) | 2017-04-09 | 2017-05-01 | ECX | N | N | ECX | 100264511 |
| 20160621 | 20061939 | 1.51 | 54 | Palliative (P) | 2016-11-13 | 2016-11-20 | ECX | N | N | ECX | 101761979 |
| 20160622 | 20061940 | 1.75 | 50 | null | 2017-03-13 | 2017-03-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100236063 |
| 20160625 | 20061941 | 1.57 | 61.2 | Adjuvant (A) | 2020-02-19 | 2020-02-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101740614 |
| 20160626 | 20061942 | 1.6 | 58 | Neo-adjuvant (N) | 2017-03-04 | 2017-03-13 | ECX | 02 | N | ECX | 100549338 |
| 20160627 | 20061943 | 1.6 | 47.5 | Adjuvant (A) | 2016-09-07 | 2016-09-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101563101 |
| 20160628 | 20061944 | 1.87 | 57.1 | Neo-adjuvant (N) | 2018-11-19 | 2018-11-29 | ECX | N | N | ECX | 100021215 |
| 20160633 | 20061945 | 1.62 | 75.9 | Palliative (P) | 2019-07-08 | 2019-08-05 | ECX | 02 | N | ECX | 100159412 |
| 20160635 | 20061946 | 1.8 | 88.4 | Palliative (P) | 2016-08-18 | 2016-08-24 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101402373 |
| 20160636 | 20061947 | 1.88 | 70.95 | Palliative (P) | 2017-04-03 | 2017-04-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100209320 |
| 20160637 | 20061948 | 1.93 | 78 | Adjuvant (A) | 2019-11-09 | 2019-11-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100054615 |
| 20160639 | 20061949 | 1.63 | 95 | Neo-adjuvant (N) | 2017-12-08 | 2017-12-08 | ECX | N | Y | ECX | 101389967 |
| 20160641 | 20061950 | 1.55 | 67.95 | Palliative (P) | 2019-08-13 | 2019-08-23 | ECX | N | null | ECX | 101377606 |
| 20160642 | 20061951 | 1.61 | 95 | Curative (C) | 2018-09-09 | 2018-09-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101804851 |
| 20160643 | 20061952 | 1.74 | 84.9 | Neo-adjuvant (N) | 2017-05-26 | 2017-05-26 | ECX | 02 | N | ECX | 100821199 |
| 20160644 | 20061953 | 1.67 | 62.2 | Adjuvant (A) | 2019-05-01 | 2019-05-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100718535 |
| 20160645 | 20061954 | 1.8 | 102 | Adjuvant (A) | 2016-09-06 | 2016-09-21 | ECX | N | N | ECX | 100665496 |
| 20160646 | 20061955 | 1.68 | 85.1 | Palliative (P) | 2017-10-19 | 2017-10-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100549750 |
| 20160647 | 20061956 | 1.7 | 85 | Palliative (P) | 2019-01-25 | 2019-01-26 | ECX | 2 | N | ECX | 100682984 |
| 20160648 | 20061957 | 1.73 | 84 | Neo-adjuvant (N) | 2016-11-29 | 2016-12-17 | ECX | 02 | N | ECX | 100146679 |
| 20160649 | 20061958 | 1.61 | 60.9 | Palliative (P) | 2020-01-24 | 2020-01-24 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100523544 |
| 20160650 | 20061959 | 1.78 | 97 | Neo-adjuvant (N) | 2018-04-16 | 2018-04-23 | ECX | 2 | N | ECX | 100463244 |
| 20160651 | 20061960 | 1.53 | 56.8 | Curative (C) | 2019-03-23 | 2019-04-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100799516 |
| 20160653 | 20061961 | 1.75 | 66 | Adjuvant (A) | 2019-06-22 | 2019-07-07 | ECX | N | null | ECX | 100995300 |
| 20160654 | 20061962 | 1.82 | 63.2 | 02 | 2017-05-31 | 2017-05-31 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100387657 |
| 20160655 | 20061963 | 1.49 | 66 | Neo-adjuvant (N) | 2017-06-14 | 2017-07-12 | ECX | N | N | ECX | 101522992 |
| 20160658 | 20061964 | 1.72 | 70 | Neo-adjuvant (N) | 2018-12-26 | 2019-01-12 | ECX | N | N | ECX | 100910839 |
| 20160660 | 20061965 | 1.77 | 78.95 | Neo-adjuvant (N) | 2018-06-07 | 2018-06-15 | ECX | 02 | N | ECX | 101112479 |
| 20160661 | 20061966 | null | null | Neo-adjuvant (N) | 2019-06-25 | 2019-06-27 | ECX | N | null | ECX | 101428397 |
| 20160663 | 20061967 | 1.78 | 78.7 | Neo-adjuvant (N) | 2017-05-15 | 2017-05-22 | ECX | N | N | ECX | 100239428 |
| 20160664 | 20061968 | null | null | Neo-adjuvant (N) | 2018-09-28 | 2018-10-15 | ECX | N | N | ECX | 101859835 |
| 20160666 | 20061969 | 1.65 | 85.3 | Neo-adjuvant (N) | 2020-01-02 | 2020-01-09 | ECX | N | Y | ECX | 100694773 |
| 20160668 | 20061970 | 1.52 | 56.4 | Palliative (P) | 2019-10-19 | 2019-10-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100312737 |
| 20160671 | 20061971 | 1.7 | 58 | Neo-adjuvant (N) | 2018-08-23 | 2018-08-23 | ECX | 2 | N | ECX | 101606609 |
| 20160672 | 20061972 | 1.75 | 76.7 | Neo-adjuvant (N) | 2018-07-06 | 2018-07-20 | ECX | 02 | N | ECX | 100029367 |
| 20160677 | 20061973 | 1.69 | 55.7 | Neo-adjuvant (N) | 2019-12-08 | 2019-12-16 | ECX | N | N | ECX | 101359355 |
| 20160678 | 20061974 | 1.77 | 52 | Adjuvant (A) | 2017-02-24 | 2017-03-10 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101108271 |
| 20160681 | 20061975 | 1.65 | 58.8 | null | 2018-04-16 | 2018-05-04 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101305879 |
| 20160684 | 20061976 | 1.78 | 71.1 | Palliative (P) | 2017-08-24 | 2017-08-27 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101353922 |
| 20160685 | 20061977 | 1.7 | 71.4 | Neo-adjuvant (N) | 2018-03-30 | 2018-04-25 | ECX | 02 | N | ECX | 100346564 |
| 20160686 | 20061978 | 1.82 | 57.7 | Curative (C) | 2018-02-21 | 2018-03-14 | ECX | N | N | ECX | 101117523 |